NEW YORK (GenomeWeb) – OpGen and Merck announced today that they will collaborate to develop rapid diagnostics and informatics tools for antibiotic resistance.

Under the terms of the deal, Merck will give OpGen access to its library of 200,000 bacterial pathogens in order to support OpGen's development of rapid DNA tests and a genomic database of antibiotic-resistant pathogens.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.